for nearly three decades. There is a great deal of evidence that they play an important role in gastrointestinal mucosal growth, but the mechanisms through which this role is carried out are still not fully explained. This review examines the role of the polyamines in the regulation of mucosal growth, the control of intracellular polyamine levels, the biosynthesis of the polyamines, and some known mechanisms of their action. Finally, we propose a model of polyamine action that reconciles the effects of various trophic agents and situations in which growth is stimulated along with concomitant changes in polyamine levels. It accounts for both humoral and gradient-oriented features of various adaptive responses of the gastrointestinal mucosa and is intended to provide a framework for the future investigation of the role of the polyamines in this tissue. ornithine decarboxylase; cu-difluoromethylornithine THIS REVIEW focuses on the role of the polyamines in the growth of the gast rointestinal mucosa as it has been elucidated by their biochemistry, the activation or inhibition of the rate-limiting enzymes ornithine decarboxylase (ODC, EC 4.1.1.17) and S-adenosyl-L-methionine decarboxylase (SAMDC, EC 4.1.1.50), their presence in luminal contents, and the experimental models that have been used to study them. We attempt to point out the gaps remaining in the story and, finally, offer a working hypothesis for the role of the polyamines in gastrointestinal mucosal growth. The literature reviewed is a selection that reflects our particular interests and is not intended to be comprehensive.
BIOCHEMISTRY
A partial diagram of polyamine biosynthesis is presented in Fig. 1 . Two primary precursors are required for the biosynthesis of the polyamines in animal tissues. The first is ornithine, a biosynthetic product of arginine not found in proteins. Ornithine is decarboxylated by the enzyme ODC to produce putrescine, the first polyamine in the biosynthetic chain. ODC is a rate-limiting enzyme for the polyamines. It can be rapidly and strikingly (several hundredfold) induced by a variety of growth stimuli. It has a very short half-life: -10-30 min in most mammalian cells (138) , 22 min in rat intestinal mucosa, and 20-35 min in cultu red rat small in .testinal crypt cells (48). Rapid inducibility and a short half-life are necessary to meet the cell's requirement for rapid response to growth stimuli.
An important endogenous inhibitor of ODC activity is the so-called "antizyme," actually a family of isoforms that may be related to multiple forms of ODC (13) . Antizyme has been isolated and partially purified from liver and other eukaryotic cells by Canellakis and coworkers (29, 40) . It was found to have a molecular weight of 26,500 (40) , to be inactivated at 55°C and by trypsin, and not to be inactivated by RNase (29, 40) (for a review, see Ref. 39 ).
Antizyme does not inhibit the synthesis of ODC but rather neutralizes it by forming ODC-antizyme complexes (39). Putrescine induced antizyme at concentrations as low as low7 to lo-' M in neuroblastoma cells in basic salts/glucose solution. In growth medium, lo-:' to lo-' M putrescine was required (2). The concentration of putrescine thus functions as a variable set point stimulating the production of antizyme, which complexes with and inactivates variable proportions of ODC. The proportion depends on the cell type and its environment. A study of the changing proportions of free to antizymebound ODC in response to isoproterenol, putrescine, and dexamethasone in the rat heart has been reported (28) using a method based on the ability of a-difluoromethylornithine (DFMO) -inactivated ODC to release active ODC from the ODC-antizyme complex (91). Such an investigation has not been reported in cells of gastroin- testinal origin but would be of value in elucidating the complex role of the polyamines.
Other endogenous factors also regulate ODC activity. These include RNA synthesis, translational control by polyamines, fluctuations in enzyme turnover, and transitions between active and inactive forms. These mechanisms have been reviewed in detail by McCann (82) .
A number of synthetic inhibitors of ODC activity have been available over the past decade (for reviews, see Refs. 51 and 138). We will consider only DFMO, one of the most potent, specific, and widely used.
DFMO is a derivative of pentanoic acid and a structural analogue of ornithine. DFMO is enzyme activated and specific for ODC, to which it binds irreversibly in place of ornithine (78). The hypothesis that the enzymatic decarboxylation of DFMO leads to the generation of a conjugated imine, which then alkylates a nucleophilic residue on the enzyme (87), has recently been supported by additional experimental evidence (100). DFMO blocks the formation of putrescine from ornithine and the further biosynthesis of spermidine and spermine. Intracellular polyamine levels can thus be lowered drastically, permitting investigations of their role in various cellular processes.
Many investigators have used DFMO to probe the mechanism of action of the polyamines. Among those that relate to the gastrointestinal mucosa are studies of the trophic effect of gastrin on the gastric mucosa (59, 86), the repair of gastric mucosal damage (140, 147, 148) , and the role of the polvamines in intestinal adaptation (22, 45, 74, 158) and regeneration (35, 142) .
L-Methionine is the second primary precursor of the polyamines. It is converted with the aid of ATP to Sadenosylmethionine, which then serves as the donor of the propylamine moiety for the synthesis of the higher polyamines. Putrescine participates in all three steps. When ODC forms putrescine, SAMDC is activated. Decarboxylated S-adenosylmethionine is formed, and putrescine can then be transformed into spermidine and spermidine into spermine by the addition of the propylamine moiety made available. Like ODC, SAMDC also has a short half-life (-1-2 h) (24, 117) but is not as inducible (110). SAMDC is markedly and specifically stimulated by putrescine and related diamines in vitro (77, 102, 107) .
Methylglyoxal bis(guanylhydrazone) (MGBG) is a specific inhibitor of mammalian putrescine-activated SAMDC (156). MGBG completely abolished the accumulation of spermidine and spermine in lymphocyte cultures (62) and inhibited DNA synthesis. The DNA synthesis inhibition could be reversed by spermidine (26). Furthermore, a mutant cell line (CHOMG) resistant to MGBG has been shown to lack a functional polyamine transport system (12).
Several bis(alkyl)polyamine derivatives, though not direct inhibitors of polyamine biosynthetic enzymes, have been shown to deplete cellular polyamine levels (9, lO4), presumably by downregulating ODC and SAMDC synthesis (105). However, a study of the effect of N1,N1'-bis(ethyl)spermine (BESM) and its analogues on human has shown that the dramatic decrease in polyamines caused by these compounds is due to a marked excretion of spermidine (101) rather than to the downregulation of biosynthetic enzymes. The two propylamine transferases, spermidine and spermine synthase, are stable enzymes with long halflives (37, 111). Diamine oxidase is widely distributed and is found in increased concentrations in rapidly proliferating tissues, including the gastrointestinal mucosa. Putrescine is a substrate for diamine oxidase (8). Polyamine oxidase catalyzes the conversion of spermine to spermidine and spermidine to putrescine but is found mainly in the liver (44). (Two reviews of polyamine biosynthesis and metabolism in greater detail are Refs. 34 and 51.)
The use of specific inhibitors of spermidine synthase and spermine synthase has shown that the regulation of ODC and SAMDC is the result of feedback regulation by various polyamines at many different levels (43). For instance, a potent competitive inhibitor of spermine synthase, N-butyl-1,3-diaminopropane, when added to growing HTC (rat hepatoma) cells caused a marked decrease of spermine and an increase in spermidine levels with no inhibition of cell growth (3). Similar N-alkylated 1,3-diaminopropane derivatives can be used to study the role of spermine in cell proliferation and differentiation.
NORMAL MUCOSAL GROWTH
Growth can be understood to have two components, an increase in cell size (hypertrophy) and an increase in cell number (hyperplasia).
Our concern is mainly with the latter as this involves cell division and proliferation. pathways with distance from the crypt base. At the tip of the villus, the fully differentiated cells are extruded into the lumen after an average residence on the villus of 3 days. Other models explain the Paneth cell lineage by saying that there are two tiers of stem cells. The upper tier produces descendents that migrate upward as in the previous model, while the lower tier produces descendents that migrate to the bottom of the crypt and differentiate into Paneth cells (10, 11) . A review of the use of chimeric and transgenic mice to probe cell lineages in the small intestine may be found in Ref. 33 .
The large intestine also contains columnar epithelial, mucous, Paneth, and enteroendocrine cells. These differentiated cells are also derived from stem cells found at the base of tubular crypts that extend down toward the muscularis mucosa (18). Villi are absent, however, and the surface at the lumen is relatively flat. Colonic mucosal cells have a turnover time of 3-4 days.
REGULATION OF MUCOSAL GROWTH
The stimulants of mucosal growth fall into three main categories. These are the gastrointestinal peptides secreted by the cells of the mucosa itself; luminal factors produced by bacteria, ingested with or released from food, or secreted by the glands of the digestive tract; and hormonal or neural signals coming from distant parts of the body.
Gastrointestinal peptides. Gastrin is released from antral and duodenal mucosa during a meal in response to vagal stimulation, distension, and digested protein. Its best known effect is to stimulate the secretion of gastric acid, but its other physiological effect is the stimulation of the growth of gastrointestinal mucosa (14, 52, 55,92). Gastrin stimulates DNA synthesis (66) and increases the DNA, RNA, and protein content of ileal (52, 56) and proximal large bowel mucosa (52, 56, 75) . Gastrin does not have trophic effects on gut smooth muscle (55) or the esophageal or antral mucosa (14, 52, 92) . Gastrin increases the number of parietal cells in the gastric mucosa but not the number of chief cells (20, 154) . Studies of the effects of exogenous gastrin on mucosal growth and the correlation between endogenous gastrin levels and mucosal growth have led to the conclusion that gastrin is a physiological regulator of the growth of the oxyntic gland mucosa and perhaps of the colonic mucosa.
Gastrin has also been shown to stimulate the growth of cells of gastrointestinal mucosal origin in culture (88). Four human colon cancer cell lines averaged a 59% increase in cell number over control when treated with pentagastrin, a synthetic analogue of gastrin (131). In another human colon cancer cell line the rate of DNA synthesis was increased 180% 8 h after treatment with gastrin (66).
Somatostatin is located in endocrine cells throughout the gastrointestinal mucosa and the pancreas. It appears to function as a paracrine peptide that inhibits gastrin release (119).
Bombesin stimulates gastrin release (118) (58, 72, 144) . EGF may act from the lumen rather than from the blood supply because milk contains EGF, and EGF is secreted by the salivary glands. In rats maintained on total parenteral nutrition (TPN) to produce a hypoproliferative intestine, EGF significantly increased the number of metaphase cells, especially in the colon. DFMO completely abolished the proliferative response of the small intestine to EGF and lowered the response in the colon, demonstrating that the proliferative response to EGF requires polyamines (32) Secretin inhibits the trophic action of gastrin on the gastrointestinal mucosa by noncompetitive inhibition of gastrin binding to its receptor (56). This inhibition includes the gastrin-stimulated increase in parietal cell number (133) and DNA synthesis in the oxyntic gland, duodenum (56), and colon (57).
Luminal factors. A variety of experimental models has been used to study the influence of luminal factors on the regulation of growth in the gut. These models can be classified generally as surgical, dietary, or naturally occurring as in development, pregnancy, or lactation. None of these models are able to isolate the effects of a single factor on mucosal growth, and this must be taken into account when drawing conclusions based on experiments using them.
The functional work load imposed by the luminal contents influences the trophic response of the gut mucosa. Nonnutritive, but actively transported, substances as Na+ placed into surgically prepared sacs of upper small intestine stimulated cell growth (19), while mannose, which is metabolized but has negligible active absorption, did not (6). At equal concentrations by weight, disaccharide infusions stimulated mucosal growth more than monosaccharides.
If hydrolysis of the disaccharides was prevented, trophic responses were abolished (152). These experiments support the conclusion that the functional work load, rather than the nutritive value of the absorbed material, seems to dictate the trophic response evoked.
The gastrointestinal mucosa readily adapts to changes in the luminal contents. When an animal is fasted, fed parenterally, or has sections of the gut surgically separated from the rest of the gut, the mucosa not receiving the luminal contents becomes hypoplastic.
The activity of enzymes associated with growth and proliferation falls to basal levels. When the luminal contents are returned, as in refeeding or infusing nutrients, the activity of these enzymes quickly rises and growth and proliferation resume. Under natural conditions in which increased amounts of food are eaten, as in pregnancy or lactation, the mucosa also responds with hyperplasia.
Dietary amines have been shown to play an important role in regulating the growth of the gastrointestinal mucosa (21). In experiments using the Thiry-Vella loop rat model in which the proximal jejunal mucosa was separated from the remainder of the gastrointestinal tract, the injection of normal rat gut contents, but not lyophilized gut contents, stimulated ODC activity lo-fold in fasted rats (136). [The lyophilization procedure completely removed dietary amines and short-chain fatty acids (73) .] The addition of 400 pmol of dimethylamine to the lyophilized gut contents restored their ability to stimulate ODC activity in the loop mucosa (136). In another experiment, osmotic minipumps were used to infuse putrescine or ethylamine into the ileum of fasted rats. Both amines stimulated ODC as well as SAMDC activity significantly and induced growth of the ileal mucosa (124).
Microbial flora in the gastrointestinal tract also contribute to the supply of luminal polyamines. Experiments with L-1210 tumor cells in mice that have been treated to eliminate intestinal flora indicate that these polyamines stimulate mucosal growth. In these mice, DFMO inhibited growth of the tumor cells; this inhibition could be overcome by feeding 10 pmol putrescine daily. In control mice, DFMO did not inhibit growth of the tumor cells (42). Luminal polyamines derived from microflora have also been shown to be responsible for the colonic mucosal hypertrophy induced by obstruction (96). The luminal polyamines may be taken up by the stem cells in the crypts and play an important role in the homeostasis of cell renewal in the normal gastrointestinal mucosa. We have found that the IEC-6 cell, a normal rat small intestine crypt stem cell, takes up ["Hlputrescine more readily from the apical than from the basolateral side and that stimulants of growth are also stimulants of ['Hlputrescine uptake (unpublished data). Fiber is another factor in the stimulation of colonic mucosal growth. In a study in which rats were fed isocaloric amounts of low-fiber synthetic diets of varying carbohydrate and protein composition for 10 days, DNA synthesis in the colonic and oxyntic gland mucosa decreased two-to fourfold. When nonnutritive cellulose was added to these diets, colonic DNA synthesis increased significantly (130). Bulk alone, however, is not sufficient to stimulate colonic mucosal growth (23, 49). It has been suggested that the fermentation of fiber, the production of short-chain fatty acids, and the consequent lowering of luminal pH account for the stimulation of mucosal growth (49). This idea, however, does not agree with the observation that decreasing pH decreases the stimulation of ODC in cultured human colon cancer cells (94). Nor does it correlate with the intracellular alkalinization that normally follows exposure to growth factors (for a review, see Ref. 115) .
Nongastrointestinal hormones. The effects of pituitary and other nongastrointestinal hormones on the growth and metabolism of the mucosa have been reviewed previously (53). The role of these hormones in the development of digestive tract mucosa has also been covered in detail by Henning (41). Little has been done to relate the actions of these hormones to polyamines.
MECHANISMS OF POLYAMINE ACTION
Although it has been repeatedly demonstrated that, in most cells, polyamine depletion leads to an inhibition of cell proliferation, the actual mechanism by which this is brought about is not thoroughly understood (99, 150). Two types of polyamine action are known, however. These are effects on membranes and the regulation of growth-related genes.
The ability of the polyamines to stabilize membranes has been known for some time (for a review, see Ref. 137) . For instance, the lateral mobility of erythrocyte proteins was decreased by organic polyamines. The action was thought to result from an interaction of the polyamines with the cytoskeleton (122). The effectiveness of the polyamines in stabilizing erythrocyte membranes was in the order spermine > spermidine > putrescine. It was a specific action effective only from the cytoplasmic side of the membrane (5). Polyamines protect membranes against lipid peroxidation by binding to the polar headgroups of the membrane (63, 139). In the stomach, the antiperoxidative properties of the polyamines were correlated with their protective effects against gastric lesions induced by acidified ethanol (89).
When mice were treated with both DFMO and MGBG to deplete polyamines, the epithelial cells of the small intestine showed swelling of the Golgi apparatus, a decrease in the amount of Golgi apparatus, and a decrease in galactosyltransferase activity. [ Galactosyltransferase is an enzymatic marker of the Golgi apparatus (114).] The Golgi apparatus was the most susceptible of various subcellular organelles to polyamine deficiency ( 120).
The role of polyamines in regulating membrane-bound enzymes, the transport of ions and metabolites, Ca"+ homeostasis, polyphosphoinositide metabolism, protein kinase C, phospholipids, and membrane fusion has been reviewed in detail by Schuber (123). It can be seen from this review that the actions of the polyamines can be tissue specific, and that none of these structural and regulatory properties have been investigated in epithelial cells of gastrointestinal origin.
The demonstration that polyamines can regulate growth-related genes has been relatively recent. An increase in ODC and in the expression of c-myc, a nuclear protein important to DNA synthesis, occur concomitantly in growth-stimulated cells (38, 135) . In COLO 320 human colon carcinoma cells depleted of polyamines by DFMO, the expression of the c-myc protooncogene was reduced by >90%. The decrease appeared to occur at the transcriptional level (16).
In isolated nuclei from control COLO 320 cells, the addition of spermidine increased [ cw-""P]UTP incorporation three to four times and c-~;yc, c-fos, and histone 2A transcription four to eight times, while ODC and cmyb gene transcription were not affected. On the other hand, in isolated nuclei from DFMO-treated COLO 320 cells, the addition of spermidine resulted in less than twofold increase in RNA transcription and no effect on any gene analyzed. The addition of spermidine was essential for the optimal performance of in vitro transcription. These results support a mechanistic link between spermidine and the transcription of the c-myc, c-fos, and H,A genes (15).
RELATIONSHIP OF POLYAMINES TO MUCOSAL GROWTH
Gastric mucosal maturation and proliferative responses of the mature mucosa appear to be the result of different processes. In the neonatal rat, ODC activity in the gastric mucosa changed little from day 14 to day 40, and inhibiting ODC activity with DFMO given to the pups and the mothers did not prevent or delay gastric mucosal maturation (86). In the mature rat, gastrin injection and refeeding after fasting are trophic stimuli for the oxyntic gland mucosa of the stomach. Although an increase in ODC activity could not be detected biochemically (trapping 14COZ evolved from [ 1-'4C]ornithine), DFMO blocked the trophic response to these stimuli. Gastrin also increased the mucosal levels of spermidine and spermine, an effect that was also blocked by DFMO. By means of a highly specific, polyclonal antibody to ODC, an increase in ODC could be observed in the proliferative zone of the gastric mucosa. It appeared that nonspecific decarboxylase activity had masked any increase in ODC activity detected biochemically (59). The increased ODC in response to gastrin occurred only in the oxyntic gland mucosa and not in antral mucosa. This specificity agreed with the observation that gastrin has no trophic effect on the antrum.
Taking a different approach, other investigators have reported that pentagastrin induced the polyamine-interconverting enzyme spermine/spermidine Nl-acetyltransferase in the oxyntic gland mucosa 200% in 8 h followed by increases of 200% in putrescine, acetylspermidine, and spermine at 16 h. DFMO did not alter the results. They concluded that the polyamine increases were not related to ODC activation (125). These results are diffiby 10.220.32.246 on June 24, 2017 http://ajpgi.physiology.org/ cult to reconcile with the fact that DFMO inhibits gastric mucosal cell proliferation.
The importance of ODC activity in damage and repair of the gastric mucosa as revealed by DFMO inhibition seems to depend on the damaging agent. Administering DFMO before NaCl, ethanol, or aspirin showed that ODC appeared to play a role in prevention or recovery from damage only in the case of NaCl. The authors concluded that ODC activity is not necessarily stimulated by damage (140) . If the damage to the gastric mucosa was caused by stress, the inhibition of ODC with DFMO did not alter the degree of damage (147) but did significantly delay recovery from the injury (148).
In the intestine, blocking polyamine biosynthesis with DFMO leads to mucosal hypoplasia and blunts the adaptive response to hyperplastic stimuli. For example, DFMO prevented the adaptive response of the intestinal mucosa to lactation (ES), jejunectomy, pancreatic-biliary diversion, and 90% small bowel resection. The mucosal polyamines were concomitantly lowered (74). When nutrition was supplied parenterally instead of luminally for 7 days, a mild hypoplasia with little change in polyamines occurred (45). EGF is a growth factor produced by the salivary glands and is normally present in the luminal contents. Recombinant human EGF was infused into the right external jugular vein with or without DFMO into rats for 72 h along with a total parenteral diet, and the vincristinearrested metaphases in various sections of the gastrointestinal tract were counted. EGF increased cell proliferation markedly in the intestine, especially in the colon. DFMO reduced EGF-stimulated cell proliferation below control levels in the small intestine but was much less effective in the colon. It was suggested that polyamine interconversion pathw 'ays might be operating to a greater extent in the colon than in the small intestine (32). However, it is likely that luminal polyamines produced by bacteria play a significant role in stimulating colonic mucosal growth.
In dogs and monkeys, the inhibition of ODC activity with DFMO led to villous atrophy of the mucosa. The investigators hypothesized that impaired polyamine metabolism delayed maturation of the epithelial cells and impaired development of the microvilli causing a fluid loss, evidenced by diarrhea, due to reduced absorptive surface area (159).
In rabbits, patching intestinal defects with adjacent serosal surfaces resulted in the growth of new intestinal mucosa. Despite the inhibitory effect of DFMO on polyamine synthesis and proliferative activity, cell migration to reepithelialize the patched defect was not affected (142). The repair of the small intestine after transient ischemia was also not affected by DFMO in rabbits (35). These findings indicate that cell proliferation is not involved in these processes and that cell migration can occur without new polyamine synthesis via ODC.
In the chick duodenum, it appears that the reverse pathway to putrescine is of major importance. In the vitamin D-deficient chick the intestinal villi are shortened by -30%. The villi can be returned to normal length the production of duodenal putrescine by two pathways, one from ornithine and one from spermidine. The putrescine increase was apparently related to the increase in cellular proliferation or differentiation that resulted in the lengthened villi (129). DFMO prevented neither the increase in duodenal spermidine N'-acetyltransferase activity nor the increase in duodenal putrescine content induced by DG1, although duodenal ODC activity was completely suppressed, demonstrating the importance of the reverse pathway (128). It is well known that in humans the activity of ODC and the concentrations of the polyamines, especially spermidine and spermine, are markedly elevated in colon cancers (68, 116) . This has also been observed in the colons of rodents treated with various chemical carcinogens (67, 116) . In rats, the administration of dimethylhydrazine increased N '-acetylspermidine levels after increases in the activity of spermidine N '-acetyltransferase in the distal colonic mucosa. At 26 wk all dimethylhydrazine-treated rats had malignant adenocarcinemas predominantly in the distal colon. When given concomitantly with dimethylhydrazine, DFMO reduced the number of tumors to one-sixth that in the dimethylhydrazine only-treated rats and reduced N '-acetylspermidine to control levels (36). It has been reported that acetylated polyamines such as N '-acetylspermidine may affect the conformation of DNA (31, 90, 141) . Halline et al. (36) have suggested that changes in N'-acetylspermidine might lead to changes in gene expression, resulting in tumors in the distal colon.
CONTROL OF INTRACELLULAR POLYAMINE LEVELS
Given the importance of the polyamines to cell proliferation and differentiation, it is not surprising that several mechanisms exist to regulate their intracellular levels. Although the polyamines are synthesized de novo within the cell, they are also transported into the cell by specific transport systems. The epithelial cells lining the gastrointestinal tract are exposed continually to polyamines that are present in the diet and sloughed cells, secreted in the bile (97), and produced by the gut microflora (96). Polyamine transport is correlated with the growth state of a variety of cells (61, 103), including cells of gastrointestinal origin (83). The carrier for putrescine in rat enterocytes has been reported to be energy dependent, saturable, ouabain insensitive, and Na' independent. The K,, was 1.23 X lo-" M and the Vmax was 2.60 X 10-l" mol. 10" cells-' l 15 min-' (65). The carrier for spermidine and spermine in isolated rat enterocytes was found to be distinct from that for putrescine.
Spermidine uptake was saturable, temperature dependent, energy dependent, inhibited by ouabain, and Na' independent.
The spermidine carrier had a K,, of 2.51 X lo-' M and a Vmax of 3.57 X lo-" mol. 10" cells-l l 15 min.
The ouabain sensitivity of the spermidine-spermine carrier was attributed to the fact that the more highly charged spermidine and spermine molecules might depend on the electrical gradient established by the Na'-K'-ATPase to a greater extent than the lessby restoring vitamin D. 
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Three routes can be used. These are 1) direct oxidation to aldehydes through polyamine oxidase (l), 2) retroconversion of spermine to spermidine and putrescine by a combination of acetylation and oxidation (80, 126) , and 3) direct release either as free polyamine or an acetylated derivative (145, 146) . Different cell types use these pathways to varying degrees. Stimulation of growth of human colon cancer cells (LoVo) (83) and normal rat small intestinal crypt cells (IEC-6) (unpublished data) with either asparagine or serum increased ODC activity and also increased ["Hlputrescine accumulation. Putrescine accumulation was increased by stimulation of uptake and inhibition of release in both cell types. In LoVo cells, uptake could be increased by >3OO-fold in spite of the concurrent stimulation of intracellular putrescine synthesis. These data indicate that the means to alter polyamine concentrations within proliferative mucosal cells are highly regulated and finely tuned to the proliferative state of the cells.
The polyamine levels within mature enterocytes and the proliferative crypt cells of the small intestine are regulated differently.
Early studies demonstrated that most ODC was localized to the enterocytes with little found in crypt cells (7, 106, 127) . Fitzpatrick et al. (27) found the same enzyme distribution, but in addition they showed that refeeding fasted rats significantly increased ODC and SAMDC levels in isolated enterocytes while producing no change in polyamine biosynthesis in proliferative crypt cells. With the aid of a highly sensitive immunocytochemical assay, refeeding fasted rats was shown to increase ODC in both cell types (60). However, an interesting difference emerged between the types of effective stimuli for the two cell types. Luminal nutrients, such as glycine, only increased ODC in the absorptive villous cells, while the trophic peptides gastrin and EGF increased activity in the proliferative crypt cells. Intracellular regulation and turnover of ODC are also different in the two cell types. Iwami et al. (48) compared the regulation of ODC in scraped rat intestinal mucosa with that in IEC-6 cells. (When using the 14C02 evolution technique, essentially all enzyme activity from scraped mucosa is due to the villous cells, while IEC-6 cells are a line of rat intestinal crypt cells.) With the use of villous cells from rats treated with cycloheximide, the time course of the decline in ODC activity yielded a half-life of -22 min. Labeling enzyme protein with ["HIDFMO resulted in a nearly identical estimation of half-life. Stimulation of enzyme activity did not alter the half-life. In mucosa from isolated gut segments in which ODC activity was stimulated by luminal glycine, the addition of 10 mM putrescine to the luminal solution enhanced the stimulation by 60-100%. In contrast, 10v7 M putrestine prevented 80% of the ODC activity stimulated by asparagine in the proliferative IEC-6 cells. The half-life of ODC in unstimulated IEC-6 cells was 20 min and increased to 35 min in cells exposed to 10 mM asparagine. Thus the polyamine content of the crypt cells is regulated in the same way as has been shown for other proliferative cells. Namely, ODC is increased by trophic hormones, an increase in the half-life of the enzyme occurs during stimulation, and putrescine inhibits the increase in ODC.
In the differentiated cells of the villus, however, ODC levels appear to be linked to luminal events. Gastrin does not increase levels of the enzyme. Instead, ODC increases in response to luminal nutrients. The same substances delivered via the blood to the serosal side are ineffective (143). Putrescine itself, when infused continually for 66 h at the rate of 1 pmol/h into the rat small intestine stimulated both mucosal ODC and SAMDC activity (124). Using in situ segments of rat intestine to isolate the effects of luminal stimulants and avoid hormone release, Jain et al. (50) examined the direct effects of topical nutrients on ODC levels. The results showed that ODC activity in jejunal mucosa is increased by direct contact with the amino acids glycine and alanine and by glucose and hypertonic NaCl within 2 h after exposure. Mannitol and nonactively absorbed fructose were without effect. The pattern 0 If ODC in creases in the various regions of the digestive tract as produced bY glycine followed the known capacities of the different regions for active absorption of amino acids. Thus ODC levels of the villous cells depend, at least in part, on the absorptive activity of the cells. The mechanisms for regulation of ODC in villous cells are different, to our knowledge, from those of all other cells examined. However, villous enterocytes are also, to our knowledge, the only nonproliferative cells in which the regulation of ODC has been studied.
STIMULATION OF MUCOSAL GROWTH BY POLYAMINES
The presence of large quantities of polyamines within the lumen of the digestive tract leads to the question of whether luminal polyamines can stimulate growth of mucosa by direct contact. This question was approached first by infusing putrescine directly into the ileal lumen of fasted rats (124). Putrescine was infused using osmotic minipumps at the rate of 1 pmol/h for 66 h. Total mucosal RNA, DNA, and protein content was greater in putrescine-treated rats compared with controls receiving NaCl. Growth was greatest in the mucosa surrounding the tip of the infusion catheter but was also observed 9 cm proximal to and distal from the catheter. Osborne and Seidel (96) the intestinally obstructed rat model. They found that orally fed antibiotics decreased the trophic response in the colonic mucosa proximal to an obstructive ligature and concluded that microflora-derived luminal polyamines modulated colonic mucosal hypertrophy induced by obstruction.
The studies described above indicate that luminal polyamines directly stimulated mucosal growth. If so, this would be a logical explanation for the various adaptive changes in mucosal growth that occur after changes in the exposure of mucosa to luminal contents. The only substances shown to have direct trophic effects on the mucosa when added to the diet are simple amines. Dimethylamine (100 pmol/g food) added to a normal diet prevented oxyntic gland and duodenal mucosal atrophy caused by antrectomy.
A similar experiment has not been done with polyamines, but the addition of 3 mg spermidine and spermine to a laboratory rat diet prevents mucosal atrophy normally seen in rats drinking a 2% solution of DFMO (J.-Y. Wang and L. R. Johnson, unpublished results). This experiment indicates that luminal polyamines can substitute for endogenous polyamines whose synthesis depends on ODC. It remains to be seen whether these substances added to the diet can directly stimulate mucosal growth in animals not depleted of endogenous polyamines.
CONCLUSIONS:
A HYPOTHESIS FOR THE REGULATION
OF MUCOSAL GROWTH
We believe that the experimental data and conclusions summarized in the foregoing brief review support the hypothesis that cell proliferation in the mucosa of the stomach, small intestine, and colon depends on the supply of polyamines to the dividing cells. Figure 2 illustrates this hypothesis using the crypt-villus unit of the small intestine as an example. The dividing cells in the crypts potentially are exposed to polyamines from four different sources. First, the stem cells themselves contain ODC and synthesize polyamines. This synthesis is under the control of trophic hormones such as gastrin and growth factors like EGF. ODC in these cells is inhibited by putrescine.
Second, polyamines present in food, secretions, and synthesized by bacteria are present in the lumen and can be absorbed by specific transport mechanisms present in enterocytes. These luminal polyamines account for the gradient-oriented effects of nutrients and secretions on mucosal growth. This portion of the hypothesis also explains the concept of "functional work load." Third, the luminal supply of polyamines is enhanced by those present in mature cells that are shed into the lumen. Because nutrients increase ODC activity in villous enterocytes and physical stimuli enhance cell shedding, this supply is augmented by the presence of food. Theoretically, this is a feedback mechanism that matches the rate of cell proliferation to the rate of cell loss. Physical stimuli and damage are known stimulators of intestinal cell proliferation. Fourth, putrescine and polyamines might reach the stem cells via a local circulation or paracrine effect. Polyamines absorbed by and synthesized in the villous cells would constitute this supply. In this way the large increase in ODC occurring in villous cells in response to nutrients would be related to cell proliferation and tissue growth. In the gastric mucosa, gastrin, EGF, and other trophic humoral agents increase ODC in the proliferative mucous neck cells (59). Because absorption by the stomach is minimal, the remainder of the model may not apply. The situation in colonic mucosa is presumed to be similar to the small intestine, although this tissue has not been examined in much detail.
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